Efficacy and safety of iGlarLixi vs IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drug(s): the SoliD randomised controlled trial

被引：0
|
作者：
Li, Y. [1 ]
Gu, W. [2 ]
Chen, L. [3 ]
Kuang, H. [4 ]
Du, J. [5 ]
Alvarez, A. [6 ]
Lauand, F. [7 ]
Souhami, E. [7 ]
Zhang, J. [8 ]
Xu, W. [9 ]
Du, Q. [8 ]
Mu, Y. [2 ]
Liu, M. [10 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Endocrinol, Beijing, Peoples R China
[3] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China
[4] Harbin Med Univ, Affiliated Hosp 1, Dept Endocrinol, Harbin, Peoples R China
[5] Dalian Med Univ, Affiliated Hosp 1, Dept Endocrinol, Dalian, Liaoning, Peoples R China
[6] Sanofi, Madrid, Spain
[7] Sanofi, Paris, France
[8] Sanofi, Beijing, Peoples R China
[9] Sanofi, Shanghai, Peoples R China
[10] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin, Peoples R China
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
790
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Oral Antidiabetic Drug Therapy in General Hospitalized Population with Type 2 Diabetes
    Pasquel, Francisco
    Fayfman, Maya
    Vellanki, Priyathama
    Haw, Sonya
    Smiley, Dawn D.
    Zhao, Liping
    Nair, Shailesh
    Weaver, Jeff
    Umpierrez, Guillermo E.
    DIABETES, 2015, 64 : A329 - A329
  • [22] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
    Wilding, J. P. H.
    Charpentier, G.
    Hollander, P.
    Gonzalez-Galvez, G.
    Mathieu, C.
    Vercruysse, F.
    Usiskin, K.
    Law, G.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1267 - 1282
  • [23] Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial
    Rosenstock, Julio
    Emral, Rifat
    Sauque-Reyna, Leobardo
    Mohan, Viswanathan
    Trescoli, Carlos
    Al Sifri, Saud
    Lalic, Nebojsa
    Alvarez, Agustina
    Picard, Pascaline
    Bonnemaire, Mireille
    Demil, Nacima
    McCrimmon, Rory J.
    DIABETES CARE, 2021, 44 (10) : 2361 - 2370
  • [24] Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial
    Joseph Proietto
    Jaret Malloy
    Dongliang Zhuang
    Mark Arya
    Neale D. Cohen
    Ferdinandus J. de Looze
    Christopher Gilfillan
    Paul Griffin
    Stephen Hall
    Thomas Nathow
    Geoffrey S. Oldfield
    David N. O’Neal
    Adam Roberts
    Bronwyn G. A. Stuckey
    Dennis Yue
    Kristin Taylor
    Dennis Kim
    Diabetologia, 2018, 61 : 1918 - 1922
  • [25] Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial
    Proietto, Joseph
    Malloy, Jaret
    Zhuang, Dongliang
    Arya, Mark
    Cohen, Neale D.
    de Looze, Ferdinandus J.
    Gilfillan, Christopher
    Griffin, Paul
    Hall, Stephen
    Nathow, Thomas
    Oldfield, Geoffrey S.
    O'Neal, David N.
    Roberts, Adam
    Stuckey, Bronwyn G. A.
    Yue, Dennis
    Taylor, Kristin
    Kim, Dennis
    DIABETOLOGIA, 2018, 61 (09) : 1918 - 1922
  • [26] Efficacy and safety of once-weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: The AMPLITUDE-D, AMPLITUDE-L and AMPLITUDE-S randomized controlled trials
    Aroda, Vanita R.
    Frias, Juan Pablo
    Ji, Linong
    Niemoeller, Elisabeth
    Nguyen-Pascal, My-Lien
    Denkel, Karl
    Espinasse, Melanie
    Guo, Hailing
    Baek, SeungJae
    Choi, JaeDuk
    Lingvay, Ildiko
    DIABETES OBESITY & METABOLISM, 2023, 25 (08): : 2084 - 2095
  • [27] Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study
    Song, Kee-Ho
    Kim, Jung Min
    Noh, Jung-Hyun
    Park, Yongsoo
    Son, Hyun-Shik
    Min, Kyong Wan
    Ko, Kyung Soo
    DIABETES & METABOLISM JOURNAL, 2013, 37 (02) : 117 - 124
  • [28] Efficacy of the Diabetes Empowerment Self-management Interactive Research (DESIRE) programme in Chinese patients with poorly controlled type 2 diabetes: a randomised controlled trial
    Cheng, Li
    Sit, Janet W. H.
    Choi, Kaichow
    Li, Xiaomei
    Long, Junhong
    Wu, Yuning
    LANCET, 2016, 388 : 9 - 9
  • [29] Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial
    Yang, Wenying
    Pan, Chang Yu
    Tou, Conrad
    Zhao, June
    Gause-Nilsson, Ingrid
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (02) : 217 - 224
  • [30] Superior glycaemic control with once-daily IDegAsp vs insulin glargine in Japanese adults with type 2 diabetes mellitus inadequately controlled with OADs: a randomised controlled, phase 3 trial
    Nakamura, S.
    Ono, Y.
    Rabol, R.
    Endahl, L.
    Onishi, Y.
    DIABETOLOGIA, 2012, 55 : S390 - S390
12345